Clinical Trial Update: The CardioMEMS Vericiguat Heart Failure Trial [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for the CardioMEMS-Vericiguat Heart Failure study; the trial is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Pulmonary Arterial Hypertension

Drugs mentioned

• Vericiguat (vericiguat)

Snippet

Sponsor: Finn Gustafsson | Conditions: Heart Failure, Pulmonary Arterial Hypertension | Phase 4 | Status: NOT_YET_RECRUITING